Synthesis of near-infrared-responsive hexagonal-phase upconversion nanoparticles with controllable shape and luminescence efficiency for theranostic applications
Restricted accessResearch articleFirst published online October, 2022
Synthesis of near-infrared-responsive hexagonal-phase upconversion nanoparticles with controllable shape and luminescence efficiency for theranostic applications
Over the past few decades, photodynamic therapy has been studied as a therapeutic method by generating singlet oxygen through activation of a photosensitizer (PS) to kill cancer cells. However, the light within the activating wavelength range of commercial photosensitizers has a low penetration depth. In this study, we designed multifunctional upconversion nanoparticles (UCNs) that can emit high-energy light by absorbing low-energy near-infrared (NIR) light with excellent tissue permeability through a fluorescence resonance energy transfer procedure. This process can produce reactive oxygen species by activating the PS. We aimed to optimize the thermal decomposition synthesis procedure to produce lanthanide-doped UCNs with a uniform size and improve the photoluminescence efficiency for an NIR-regulated theranostic system. It was confirmed that the morphologies of UCNs can be controlled by varying the reaction time, reaction temperature, and feed molar ratio of the solvent and reactant. The crystalline morphology of the synthesized UCNs showed a thermodynamically stable hexagonal phase. The photoluminescence efficiency of the UCNs also was influenced by size, surface area, crystalline property, and stability in aqueous solution. Furthermore, the surface-modified UCNs with a folic acid-conjugated block copolymer and PS exhibited enhanced singlet oxygen generation and significantly improved aqueous solubility and photoluminescence efficiency.
KesselD. Photodynamic therapy: a brief history. J Clin Med2019; 8(10): 1581–1587.
2.
LanMZhaoSLiuW, et al.Photosensitizers for photodynamic therapy. Adv Healthcare Mater2019; 8(13): 1900132–1900168.
3.
ShiXZhangCYGaoJ, et al.Recent advances in photodynamic therapy for cancer and infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol2019; 11(5): e1560–e1582.
4.
YanovskyRLBartensteinDWRogersGS, et al.Photodynamic therapy for solid tumors: a review of the literature. Photodermatol Photoimmunol Photomed2019; 35(5): 295–303.
ZhouZSongJNieL, et al.Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev2016; 45(23): 6597–6626.
7.
ZhouZSongJTianR, et al.Activatable singlet oxygen generation from lipid hydroperoxide nanoparticles for cancer therapy. Angew Chem2017; 129(23): 6592–6596.
8.
LiZYangFWuD, et al.Ce6-Conjugated and polydopamine-coated gold nanostars with enhanced photoacoustic imaging and photothermal/photodynamic therapy to inhibit lung metastasis of breast cancer. Nanoscale2020; 12(43): 22173–22184.
9.
TengKXChenWKNiuLY, et al.BODIPY‐based photodynamic agents for exclusively generating superoxide radical over singlet oxygen. Angew Chem2021; 133(36): 20065–20073.
10.
CuiSSYinDYChenYQ, et al.In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. Acs Nano2013; 7(1): 676–688.
11.
HuangZXuHPMeyersAD, et al.Photodynamic therapy for treatment of solid tumors - Potential and technical challenges. Technol Cancer Res T2008; 7(4): 309–320.
12.
OarMASerinJADichtelWR, et al.Photosensitization of singlet oxygen via two-photon-excited fluorescence resonance energy transfer in a water-soluble dendrimer. Chem Mater2005; 17(9): 2267–2275.
13.
ShanJBudijonoSJHuG, et al.Pegylated composite nanoparticles containing upconverting phosphors and meso‐tetraphenyl porphine (TPP) for Photodynamic Therapy. Adv Funct Mater2011; 21(13): 2488–2495.
14.
WangCTaoHQChengL, et al.Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials2011; 32(26): 6145–6154.
15.
DuYPXuBFuT, et al.Near-infrared Photoluminescent Ag2S quantum dots from a single source precursor. J Am Chem Soc2010; 132(5): 1470–1471.
16.
TsaiYCVijayaraghavanPChiangWH, et al.Targeted delivery of functionalized upconversion nanoparticles for externally triggered photothermal/photodynamic therapies of brain glioblastoma. Theranostics2018; 8(5): 1435–1448.
17.
ZhouJYuMXSunY, et al.Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials2011; 32(4): 1148–1156.
18.
XueWDiZZhaoY, et al.DNA-mediated coordinative assembly of upconversion hetero-nanostructures for targeted dual-modality imaging of cancer cells. Chin Chem Lett2019; 30(4): 899–902.
19.
LiLLZhangRBYinLL, et al.Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes. Angew Chem Int Edit2012; 51(25): 6121–6125.
20.
GaiSLLiCXYangPP, et al.Recent progress in rare earth micro/nanocrystals: soft chemical synthesis, luminescent properties, and biomedical applications. Chem Rev2014; 114(4): 2343–2389.
21.
KamimuraMOmotoAChiuHC, et al.Enhanced red upconversion emission of NaYF4:Yb3+, Er3+, Mn2+ nanoparticles for near-infrared-induced photodynamic therapy and fluorescence imaging. Chem Lett2017; 46(8): 1076–1078.
22.
WangCChengLLiuZ. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics2013; 3(5): 317–330.
23.
AraiMSde CamargoASS. Exploring the use of upconversion nanoparticles in chemical and biological sensors: from surface modifications to point-of-care devices. Nanoscale Adv2021; 3: 5135–5165.
24.
MelleSCalderónOGLaurentiM, et al.Forster resonance energy transfer distance dependence from upconverting nanoparticles to quantum dots. J Phys Chem C2018; 122(32): 18751–18758.
25.
XuSXuSZhuY, et al.A novel upconversion, fluorescence resonance energy transfer biosensor (FRET) for sensitive detection of lead ions in human serum. Nanoscale2014; 6(21): 12573–12579.
26.
ChenGQiuHPrasadPN, et al.Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev2014; 114(10): 5161–5214.
27.
JiangMLiuXChenZ, et al.Near-infrared-detached adhesion enabled by upconverting nanoparticles. Iscience2020; 23(2): 100832–100848.
28.
WuTBrandaNR. Using low-energy near infrared light and upconverting nanoparticles to trigger photoreactions within supramolecular assemblies. Chem Commun2016; 52(56): 8636–8644.
29.
WangFLiuXG. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev2009; 38(4): 976–989.
HaaseMSchaferH. Upconverting nanoparticles. Angew Chem Int Edit2011; 50(26): 5808–5829.
32.
LiJZhaoQShiF, et al. NIR‐mediated nanohybrids of upconversion nanophosphors and fluorescent conjugated polymers for high‐efficiency antibacterial performance based on fluorescence resonance energy transfer. Adv Healthcare Mater2016; 5(23): 2967–2971.
33.
JanjuaRAGaoCDaiR, et al.Na+-driven nucleation of NaYF4: Yb, Er nanocrystals and effect of temperature on their structural transformations and luminescent properties. J Phys Chem C2018; 122(40): 23242–23250.
34.
LiuJLiuYLiuQ, et al.Iridium (III) complex-coated nanosystem for ratiometric upconversion luminescence bioimaging of cyanide anions. J Am Chem Soc2011; 133(39): 15276–15279.
35.
HeerSKompeKGudelHU, et al.Highly efficient multicolour upconversion emission in transparent colloids of lanthanide-doped NaYF4 nanocrystals. Adv Mater2004; 16: 23–24.
36.
WangFHanYLimCS, et al.Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature2010; 463(7284): 1061–1065.
37.
ParkYIKimJHLeeKT, et al.Nonblinking and nonbleaching upconverting nanoparticles as an optical imaging nanoprobe and T1 magnetic resonance imaging contrast agent. Adv Mater2009; 21(44): 4467–4471.
38.
OnoderaRMotoyamaKArimaH. Design and evaluation of folate-appended methyl-beta-cyclodextrin as a new antitumor agent. J Incl Phenom Macro2011; 70(3–4): 321–326.
39.
AssarafYGLeamonCPReddyJA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Update2014; 17(4–6): 89–95.
40.
ElaminKMMotoyamaKHigashiT, et al.Dual targeting system by supramolecular complex of folate-conjugated methyl-beta-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer. Int J Biol Macromol2018; 113: 386–394.
41.
FernandezMJavaidFChudasamaV. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci2018; 9(4): 790–810.
42.
LiuCWangHLiX, et al.Monodisperse, size-tunable and highly efficient β-NaYF 4: Yb, Er (Tm) up-conversion luminescent nanospheres: controllable synthesis and their surface modifications. J Mater Chem2009; 19(21): 3546–3553.
43.
ZouHXJinFMSongXY, et al.Singlet oxygen generation of photosensitizers effectively activated by Nd3+-doped upconversion nanoparticles of luminescence intensity enhancing with shell thickness decreasing. Appl Surf Sci2017; 400: 81–89.
44.
ChoiJLeeSEParkJS, et al.Gold nanorod‐photosensitizer conjugates with glutathione‐sensitive linkages for synergistic cancer photodynamic/photothermal therapy. Biotechnol Bioeng2018; 115(5): 1340–1354.
45.
GökselMDurmuşMAtillaD. A comparative study on photophysical and photochemical properties of zinc phthalocyanines with different molecular symmetries. J Porphyrins Phthalocyanines2012; 16: 895–906.
46.
UlianaMPPiresLPratavieiraS, et al.Photobiological characteristics of chlorophyll a derivatives as microbial PDT agents. Photochem Photobiol Sci2014; 13(8): 1137–1145.
47.
SunLDDongHZhangPZ, et al.Upconversion of rare earth nanomaterials. Annu Rev Phys Chem2015; 66: 619–642.
48.
ChenJZhaoJX. Upconversion nanomaterials: synthesis, mechanism, and applications in sensing. Sensors2012; 12(3): 2414–2435.
49.
FerrandoR. Structure and properties of nanoalloys. Amsterdam: Elsevier, 2016.
RatkeLVoorheesPW. Growth and coarsening: Ostwald ripening in material processing. Berlin: Springer, 2002.
52.
AuzelF. Upconversion and anti-stokes processes with f and d ions in solids. Chem Rev2004; 104(1): 139–174.
53.
GaoCZhengPLiuQ, et al.Recent advances of upconversion nanomaterials in the biological field. Nanomaterials (Basel)2021; 11(10): 2474–2493.
54.
LiDÅgrenHChenG. Near infrared harvesting dye-sensitized solar cells enabled by rare-earth upconversion materials. Dalton Trans2018; 47(26): 8526–8537.
55.
ShinKJungTLeeE, et al.Distinct mechanisms for the upconversion of NaYF 4: Yb 3+, Er 3+ nanoparticles revealed by stimulated emission depletion. Phys Chem Chem Phys2017; 19(15): 9739–9744.
56.
LiZQZhangY. An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF(4): Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence. Nanotechnology2008; 19(34): 345606–345610.
57.
HeerSKömpeKGüdelHU, et al.Highly efficient multicolour upconversion emission in transparent colloids of lanthanide‐doped NaYF4 nanocrystals. Adv Mater2004; 16(23–24): 2102–2105.
58.
YiGSChowGM. Synthesis of hexagonal‐phase NaYF4: Yb, Er and NaYF4: Yb, Tm nanocrystals with efficient up‐conversion fluorescence. Adv Funct Mater2006; 16(18): 2324–2329.
59.
LiDDongBBaiX, et al.Influence of the TGA modification on upconversion luminescence of hexagonal-phase NaYF4: Yb3+, Er3+ nanoparticles. J Phys Chem C2010; 114(18): 8219–8226.
ZhaoLKimTHAhnJC, et al.Highly efficient “theranostics” system based on surface-modified gold nanocarriers for imaging and photodynamic therapy of cancer. J Mater Chem B2013; 1(42): 5806–5817.
62.
ChadwickSJSalahDLiveseyPM, et al.Singlet oxygen generation by laser irradiation of gold nanoparticles. J Phys Chem C2016; 120(19): 10647–10657.
63.
Ruiz-GonzálezRMilánPBresolí-ObachR, et al.Photodynamic synergistic effect of pheophorbide a and doxorubicin in combined treatment against tumoral cells. Cancers2017; 9(2): 18–35.
